Technology to reduce drinking and improve HIV viral suppression in Florida
Technology-based assessments and intervention to reduce alcohol consumption and improve HIV viral suppression in the Florida Cohort
This project uses apps, surveys, and a wearable alcohol sensor to help people with HIV in Florida who drink alcohol reduce drinking and keep their HIV virus suppressed.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Florida NIH-funded |
| Lab location | 1 site (Gainesville, United States) |
| Project ID | NIH-11137611 on NIH RePORTER |
What this research studies
You would be invited to join the Florida Cohort and answer surveys about alcohol use, mental health, medication taking, and HIV care. The team plans to enroll about 1,200 people across the state with extra outreach to those who drink heavily, and a smaller group of 80 participants will wear a wrist alcohol biosensor and report drinking for one month. Researchers will link your survey answers to statewide HIV data and may offer or study app-based supports like PositiveLinks. The project aims to learn what helps people take their HIV medication and achieve lasting viral suppression when alcohol use is present.
Who could benefit from this research
Good fit: Adults living with HIV in Florida, especially those who drink alcohol regularly or heavily, are the ideal participants.
Not a fit: People without HIV, people who do not drink alcohol, those living outside Florida, or those unwilling to use apps or wear a sensor are unlikely to benefit from participating.
Why it matters
Potential benefit: This work could help people with HIV who drink to reduce alcohol use and maintain HIV viral suppression using practical tech-based supports.
How similar studies have performed: App-based adherence programs and cohort studies have shown promise for improving HIV care, but combining continuous alcohol biosensors with large cohort data is a newer approach.
Where this research is happening
Gainesville, United States
- University of Florida — Gainesville, United States (Active)
Researchers
- Principal investigator: Cook, Robert L — University of Florida
- Study coordinator: Cook, Robert L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.